Moderna President Stephen Hoge Acquires Vested RSUs and Disposes Shares for Tax Obligations

Executive Summary

On August 31, 2026, Moderna, Inc. ($MRNA) filed a Form 4 on behalf of its President, Stephen Hoge. The filing details standard equity compensation events consisting of restricted stock unit (RSU) vestings and associated share withholdings to satisfy tax obligations on August 27 and August 28, 2026.

Transaction Details

1. August 27, 2026:

   • RSU Conversion (Code M): 1,437 RSUs converted to Common Stock at $0.00 per share.
   • Tax Withholding (Code F): 695 shares were disposed of at $149.66 per share ($104,013.70 total value) to satisfy tax liabilities.

2. August 28, 2026:

   • RSU Conversion (Code M): 611 RSUs converted to Common Stock at $0.00 per share.
   • Tax Withholding (Code F): 296 shares were disposed of at $142.77 per share ($42,260.02 total value) to satisfy tax liabilities.

Post-Transaction Holdings

• Direct Holdings: 1,484,905 shares of Common Stock.
• Indirect Holdings:
  • 4,116 shares held by Valhalla, LLC.
  • 151,933 shares held by Trust for the benefit of Dr. Hoge's spouse and children.
• Derivative Holdings (Unvested RSUs): 8,621 RSUs remaining from the February 2024 grant and 1,221 RSUs remaining from the February 2023 grant.

Market and Sentiment Impact

• Trading Significance: Low. These transactions reflect pre-scheduled RSU vesting and routine tax-related share withholdings rather than discretionary open-market buying or selling.